The health insurance industry has been in a state of flux for years now, driven to make sweeping changes by the Affordable Care Act and a new interest in finding ways to limit healthcare spending into the future. Health insurance companies need to get smarter and sleeker if they’re going to maximize profits in this new era.
One aspect of that is likely not going to change much, though. Identifying fraudulent claims and avoiding paying them is a key element to keeping margins healthy and costs down. That’s why ExamWorks (EXAM) , an independent medical examination (IME) firm, could be well positioned for the future. The company conducts medical examinations to settle disputes regarding the veracity of injury claims, with clients ranging from the Federal Government to insurance companies.
The Equities.com Research Team dug into ExamWorks to take a look at the company’s prospects and determine whether it has potential as an investment. The team found that the company’s unique size and strategy of growth by acquisition could make it an intriguing play tangential to the health care sector.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer